Drug details

Brilinta (ticagrelor tablets for oral administration)

type of Antiplatelet Agents, Hematologic

Brilinta (ticagrelor) is a blood-thinner used to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS). Brilinta works by preventing the formation of new blood clots, thus maintaining blood flow in the body to help reduce the risk of another cardiovascular event.

This drug may have the following side effects:

• headache
• cough
• nausea
• diarrhea
• dizziness
• nosebleeds
• back pain
• low blood pressure
• fatigue, and 
• high blood pressure
• irregular heartbeat
• bruising
• bleeding more easily
• chest pain.

The following drugs are related to Brilinta, either as a replacement or used together:

• Afeditab CR (nifedipine extended-release tablets)
• Norvasc (amlodipine besylate)
• Lipitor (atorvastatin calcium)
• Cardizem (diltiazem hydrochloride)
• Cardizem CD (diltiazem hcl)
• Cardizem LA (diltiazem)
• Cardura (doxazosin mesylate)
• Cardura XL (doxazosin mesylate extended release tablets)
• Plavix (clopidogrel bisulfate)
• Welchol (colesevelam hcl)
• Dilatrate SR (isosorbide dinitrate sustained release capsules)
• Zetia (ezetimibe tablets)
• Lescol (fluvastatin sodium)